Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Springer Nature Link
Log in

Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study

  • Neuro
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To investigate different brain regions for grey (GM) and white matter (WM) damage in a well-defined cohort of neuromyelitis optica spectrum disorder (NMOSD) patients and compare advanced MRI techniques (VBM, Subcortical and cortical analyses (Freesurfer), and DTI) for their ability to detect damage in NMOSD.

Methods

We analyzed 21 NMOSD patients and 21 age and gender matched control subjects. VBM (GW/WM) and DTI whole brain (TBSS) analyses were performed at different statistical thresholds to reflect different statistical approaches in previous studies. In an automated atlas-based approach, Freesurfer and DTI results were compared between NMOSD and controls.

Results

DTI TBSS and DTI atlas based analysis demonstrated microstructural impairment only within the optic radiation or in regions associated with the optic radiation (posterior thalamic radiation p < 0.001, 6.9 % reduction of fractional anisotropy). VBM demonstrated widespread brain GM and WM reduction, but only at exploratory statistical thresholds, with no differences remaining after correction for multiple comparisons. Freesurfer analysis demonstrated no group differences.

Conclusion

NMOSD specific parenchymal brain damage is predominantly located in the optic radiation, likely due to a secondary degeneration caused by ON. In comparison, DTI appears to be the most reliable and sensitive technique for brain damage detection in NMOSD.

Key Points

• The hypothesis of a widespread brain damage in NMOSD is challenged.

• The optic radiation (OR) is the most severely affected region.

• OR-affection is likely due to secondary degeneration following optic neuritis.

• DTI is currently the most sensitive technique for NMOSD-related brain-damage detection.

• DTI is currently the most reliable technique for NMOSD-related brain-damage detection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig 2
Fig. 3

Similar content being viewed by others

References

  1. Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1165–1173

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149–164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Filippi M, Rocca MA, Moiola L et al (1999) MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology 53:1705–1705

    Article  CAS  PubMed  Google Scholar 

  4. Rocca MA, Agosta F, Mezzapesa DM et al (2004) Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 62:476–478

    Article  CAS  PubMed  Google Scholar 

  5. Yu CS, Lin FC, Li KC et al (2006) Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 27:1009–1015

    CAS  PubMed  Google Scholar 

  6. Yu C, Lin F, Li K et al (2008) Pathogenesis of Normal-appearing White Matter Damage in Neuromyelitis Optica: Diffusion-Tensor MR Imaging. Radiology 246:222–228

    Article  PubMed  Google Scholar 

  7. Bichuetti DB, Rivero RLM, de Oliveira EML et al (2008) White matter spectroscopy in neuromyelitis optica: a case control study. J Neurol 255:1895–1899

    Article  PubMed  Google Scholar 

  8. Aboul-Enein F, Krssák M, Höftberger R et al (2010) Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol 31:76–79

    Article  CAS  PubMed  Google Scholar 

  9. de Seze J, Blanc F, Kremer S et al (2010) Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry 81:409–411

    Article  PubMed  Google Scholar 

  10. Calabrese M, Oh MS, Favaretto A et al (2012) No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 79:1671–1676

    Article  PubMed  Google Scholar 

  11. Rueda Lopes FC, Doring T, Martins C et al (2012) The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study. Radiology 263:235–242

    Article  PubMed  Google Scholar 

  12. Zhao D-D, Zhou H-Y, Wu Q-Z et al (2012) Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques. NeuroImage 59:3173–3177

    Article  PubMed  Google Scholar 

  13. Jeantroux J, Kremer S, Lin XZ et al (2012) Diffusion tensor imaging of normal-appearing white matter in neuromyelitis optica. J Neuroradiol J Neuroradiol 39:295–300

    Article  CAS  PubMed  Google Scholar 

  14. Liu Y, Duan Y, He Y et al (2012) A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler Houndmills Basingstoke Engl 18:1013–1021

    Article  Google Scholar 

  15. Pichiecchio A, Tavazzi E, Poloni G et al (2012) Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler Houndmills Basingstoke Engl 18:817–824

    Article  CAS  Google Scholar 

  16. Duan Y, Liu Y, Liang P et al (2012) Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study. Eur J Radiol 81:e110–e114

    Article  PubMed  Google Scholar 

  17. Blanc F, Noblet V, Jung B et al (2012) White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One 7:e33878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Chanson J-B, Lamy J, Rousseau F et al (2013) White matter volume is decreased in the brain of patients with neuromyelitis optica. Eur J Neurol 20:361–367

    Article  PubMed  Google Scholar 

  19. Kimura MCG, Doring TM, Rueda FC et al (2014) In vivo assessment of white matter damage in neuromyelitis optica: a diffusion tensor and diffusion kurtosis MR imaging study. J Neurol Sci 345:172–175

    Article  PubMed  Google Scholar 

  20. von Glehn F, Jarius S, Cavalcanti Lira RP et al (2014) Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler. doi:10.1177/1352458513519838

    Google Scholar 

  21. Doring TM, Lopes FCR, Kubo TTA et al (2014) Neuromyelitis optica: a diffusional kurtosis imaging study. AJNR Am J Neuroradiol 35:2287–2292

    Article  CAS  PubMed  Google Scholar 

  22. Duan Y, Liu Y, Liang P et al (2014) White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study. Acta Radiol 55:589–593

    Article  PubMed  Google Scholar 

  23. Lopes FCR, Alves-Leon SV, Godoy JM et al (2015) Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI. J Neuroimaging Off J Am Soc Neuroimaging. doi:10.1111/jon.12191

    Google Scholar 

  24. Kremer S, Renard F, Achard S et al (2015) Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol 72:815–822

    Article  PubMed  PubMed Central  Google Scholar 

  25. Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflammation 10:8

    PubMed  PubMed Central  Google Scholar 

  26. Jarius S, Paul F, Franciotta D et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202–214

    CAS  PubMed  Google Scholar 

  27. Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112

    Article  CAS  PubMed  Google Scholar 

  28. Lennon VA, Kryzer TJ, Pittock SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Metz I, Beißbarth T, Ellenberger D et al (2016) Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2016;3:e204

  30. Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489

    Article  CAS  PubMed  Google Scholar 

  31. Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kister I, Paul F (2015) Pushing the boundaries of neuromyelitis optica: does antibody make the disease? Neurology 85:118–119

    Article  PubMed  Google Scholar 

  33. Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 9:14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Cabrera-Gómez JA, Quevedo-Sotolongo L, González-Quevedo A et al (2007) Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler Houndmills Basingstoke Engl 13:186–192

    Article  Google Scholar 

  35. Li Y, Xie P, Lv F et al (2008) Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 118:218–225

    Article  CAS  PubMed  Google Scholar 

  36. Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80:1330–1337

    Article  PubMed  PubMed Central  Google Scholar 

  37. Sinnecker T, Dörr J, Pfueller CF et al (2012) Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79:708–714

    Article  PubMed  Google Scholar 

  38. Kister I, Herbert J, Zhou Y, Ge Y (2013) Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica. Mult Scler Int 2013:398259

    PubMed  PubMed Central  Google Scholar 

  39. Pittock SJ, Lennon VA, Krecke K et al (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390–396

    Article  PubMed  Google Scholar 

  40. Tackley G, Kuker W, Palace J (2014) Magnetic resonance imaging in neuromyelitis optica. Mult Scler J 20:1153–1164

    Article  Google Scholar 

  41. Chan K, Tse CT, Chung CP et al (2011) Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol 68:1432–1439

    Article  PubMed  Google Scholar 

  42. He D, Wu Q, Chen X et al (2011) Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse. Brain Cogn 77:80–88

    Article  PubMed  Google Scholar 

  43. Rocca MA, Parisi L, Pagani E et al (2014) Regional but not global brain damage contributes to fatigue in multiple sclerosis. Radiology 273:511–520

    Article  PubMed  Google Scholar 

  44. Rueda Lopes FC, Doring T, Martins C et al (2012) The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study. Radiology 263:235–242

    Article  PubMed  Google Scholar 

  45. de Seze J, Blanc F, Kremer S et al (2010) Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry 81:409–411

    Article  PubMed  Google Scholar 

  46. Yu CS, Zhu CZ, Li KC et al (2007) Relapsing Neuromyelitis Optica and Relapsing-Remitting Multiple Sclerosis: Differentiation at Diffusion-Tensor MR Imaging of Corpus Callosum 1. Radiology 244:249–256

    Article  PubMed  Google Scholar 

  47. Wingerchuk DM, Lennon VA, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815

    Article  CAS  PubMed  Google Scholar 

  48. Dalmau J (2015) Observations on the evolving fields of neuroimmunology and neuroinflammation. Neurol Neuroimmunol Neuroinflammation 2:e67

    Article  Google Scholar 

  49. Kitley J, Leite MI, Nakashima I et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain J Neurol 135:1834–1849

    Article  Google Scholar 

  50. Ashburner J (2007) A fast diffeomorphic image registration algorithm. NeuroImage 38:95–113

    Article  PubMed  Google Scholar 

  51. Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97:11050–11055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Desikan RS, Ségonne F, Fischl B et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31:968–980

    Article  PubMed  Google Scholar 

  53. Fischl B, Salat DH, Busa E et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355

    Article  CAS  PubMed  Google Scholar 

  54. Fischl B (2012) FreeSurfer. NeuroImage 62:774–781

    Article  PubMed  PubMed Central  Google Scholar 

  55. Jenkinson M, Beckmann CF, Behrens TEJ et al (2012) FSL. NeuroImage 62:782–790

    Article  PubMed  Google Scholar 

  56. Smith SM, Jenkinson M, Johansen-Berg H et al (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31:1487–1505

    Article  PubMed  Google Scholar 

  57. Oberwahrenbrock T, Ringelstein M, Jentschke S et al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler 19:1887–1895

    Article  PubMed  Google Scholar 

  58. Tewarie P, Balk L, Costello F et al (2012) The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment. PLoS One 7:e34823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 44:83–98

    Article  PubMed  Google Scholar 

  60. Højsgaard S, Halekoh U, Yan J (2006) The R Package geepack for Generalized Estimating Equations. J Stat Softw 15(2):1–11

    Google Scholar 

  61. Gabilondo I, Martínez-Lapiscina EH, Fraga-Pumar E et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77:517–528

    Article  PubMed  Google Scholar 

  62. Sinnecker T, Oberwahrenbrock T, Metz I et al (2015) Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study. Eur Radiol 25:122–131

    Article  PubMed  Google Scholar 

  63. Pfueller CF, Brandt AU, Schubert F et al (2011) Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One 6:e18019

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Popescu BFG, Parisi JE, Cabrera-Gómez JA et al (2010) Absence of cortical demyelination in neuromyelitis optica. Neurology 75:2103–2109

    Article  PubMed  PubMed Central  Google Scholar 

  65. Simó M, Rifà-Ros X, Rodriguez-Fornells A, Bruna J (2013) Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev 37:1311–1321

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Prof. Dr. med. Friedemann Paul. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. This study has received funding from the Bundesministerium für Bildung und Forschung (BMBF Competence Network Multiple Sclerosis to FP, FlP, JW and KR) and by Deutsche Forschungsgemeinschaft (Exc 257 to FP), as well as from BIH-Charité Clinical Scientist Program funded by the Charité- Universitätsmedizin Berlin and the Berlin Institute of Health (to FlP). No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained.

Written informed consent was obtained from all subjects (patients) in this study. Methodology:

Prospective, cross sectional study, one institution.

Author information

Authors and Affiliations

  1. NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité- Universitätsmedizin Berlin, Berlin, Germany

    F. Pache, H. Zimmermann, A. Lacheta, S. Papazoglou, J. Kuchling, J. Wuerfel, F. Paul, A. U. Brandt & M. Scheel

  2. Department of Neurology, Charité- Universitätsmedizin Berlin, Berlin, Germany

    F. Pache, C. Finke, K. Ruprecht & F. Paul

  3. Berlin School of Mind and Brain, Humboldt-Universitaet zu Berlin, Berlin, Germany

    C. Finke

  4. Department of Radiology, Charité- Universitätsmedizin Berlin, Berlin, Germany

    B. Hamm & M. Scheel

Authors
  1. F. Pache
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Finke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Lacheta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Papazoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Kuchling
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Wuerfel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K. Ruprecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. U. Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M. Scheel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Pache.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 1648 kb)

ESM 2

(DOC 53 kb)

ESM 3

(DOC 62 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pache, F., Zimmermann, H., Finke, C. et al. Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study. Eur Radiol 26, 4413–4422 (2016). https://doi.org/10.1007/s00330-016-4282-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-016-4282-x

Keywords

Search

Navigation